Ocular Manifestations of COVID-19 (SARS-CoV-2): A Critical Review of Current Literature.

The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in China in the city of Wuhan in December of 2019 and since then more than 5,000,000 people have been infected, with approximately 338,000 deaths worldwide. The virus causes the coronavirus disease 2019 (COVID-19), which is characterized by fever, myalgia and cough, with severe acute respiratory syndrome being the most fearsome complication. Nevertheless, the vast majority of cases present mild symptoms or none. Central nervous system and cardiovascular manifestations have been reported. The range of ocular manifestations, either as a result of the infection or as a result of the treatment, has not yet been discussed. In this study, a systematic review of current literature relevant to COVID-19 was performed with focus on modes of transmission, ocular manifestations related to infection and medications, as well as the control of infection in ophthalmic practice.

IgG4-rich reactive lymphoid hyperplasia of the lacrimal gland.

We describe an otherwise healthy 24-year-old woman with reactive lymphoid hyperplasia of one lacrimal gland. She was found to have modest elevation of serum IgG4 and high density of IgG4+ plasma cells in her lacrimal gland, ranging from 40% to 60% of IgG+ plasma cells. The patient transiently responded to systemic corticosteroids before treatment with rituximab. IgG4-rich reactive lymphoid hyperplasia of the lacrimal gland is neither an established part of IgG4-related disease spectrum nor a known precursor lesion to lymphoma. Although there is a plausible risk of transforming to IgG4-related disease or to lymphoma, the biological potential and natural history of IgG4-rich reactive lymphoid hyperplasia remains to be determined.

Un caso pediátrico de hemolacria / A pediatric case of haemolacria

Introducción: la presencia de lágrimas con sangre -o hemolacria- es un hecho infrecuente en la práctica clínica, y ha sido denominada con distintas acepciones en la literatura médica. Las causas que originan este signo son múltiples, y comprenden desde trastornos locales en el globo ocular, hasta enfermedades sistémicas, además de las provocadas en forma artificial y en otras. En ocasiones su etiología no se ha podido demostrar. Presentación del caso: adolescente, mestiza, de 16 años de edad que fue remitida al Hospital Docente Pediátrico del Cerro por el policlínico de su área de salud, porque presentó lágrimas con sangre con epistaxis acompañada de cefaleas y calambres en extremidades inferiores, además de referir un síndrome de inmunodeficiencia adquirida desde los 13 años. Durante su estadía hospitalaria se constató en dos ocasiones hemolacria con epistaxis. Los exámenes complementarios realizados para diagnosticar algún trastorno de la coagulación, enfermedad local o sistémica no transmisible, resultaron normales. Se indicó tratamiento con antirretrovirales para su afección de base. Se explicó la posible fisiopatología de este fenómeno. Conclusiones: la causa de esta entidad en la presente comunicación queda por precisar, y es el primer caso pediátrico reportado en Cuba(AU)

Introduction: the presence of tears with blood -or haemolacria- is an uncommon event in clinical practice which has been defined in several different manners in medical literature. The causes giving rise to this sign are many, ranging from local disorders in the eyeball to systemic diseases, alongside those brought about by artificial agents and others. On occasion it has not been possible to determine its etiology. Case presentation: a mulatto 16-year-old female adolescent was referred by the polyclinic in her health area to the Pediatric University Hospital in the municipality of Cerro with bloody tears and epistaxis accompanied by headaches and cramp in her lower limbs. The patient stated she had suffered from an acquired immunodeficiency syndrome since the age of 13. During her stay in hospital two episodes of haemolacria with epistaxis could be observed. The complementary tests performed to diagnose some other coagulation disorder, local condition or non-communicable systemic disease were all normal. Treatment with antiretrovirals was indicated for her underlying disease. The possible physiopathology of the phenomenon was explained. Conclusions: the cause of the condition discussed in the present communication is still to be determined. This is the first pediatric case of haemolacria reported in Cuba(AU)

Clinicoserological factors associated with response to steroid treatment and recurrence in patients with IgG4-related ophthalmic disease.

PURPOSE: To investigate the factors associated with response to steroid treatment and recurrence in patients with IgG4-related ophthalmic disease (ROD). METHODS: Twenty-eight patients with biopsy-proven IgG4-ROD treated between March 2010 and January 2017 were included in this retrospective study. Clinical features, serum IgG4 levels, systemic involvement, treatments and treatment outcome, factors associated with response to treatment and recurrence were assessed. RESULT: Thirteen men and 15 women (mean age 50.8 years) were evaluated over mean follow-up period of 27.3 months. Elevated serum IgG4 levels (>1.35 g/L) and systemic disease were noted in 9 (32%) and 18 patients (64%), respectively. The lacrimal gland was involved in all patients, and 22 patients (78.6%) had bilateral involvement. Most patients (82%) responded well to systemic steroids, but 12 (43%) relapsed after the initial steroid treatment, requiring additional therapies to achieve remission. Complete response to initial steroid treatment was associated with elevated serum IgG4 levels before treatment (P=0.001) and bilateral orbital involvement (P=0.050). Recurrence was associated with elevated serum IgG4 levels before treatment (P=0.007), lower dose (P=0.057) and shorter duration of initial steroids (P=0.042). Patients with recurrence eventually required significantly more steroids than those without recurrence (P=0.011). CONCLUSIONS: Patients with IgG4-ROD responded well to systemic steroid treatment, but recurrence was common, particularly among those with elevated serum IgG4 levels and shorter duration of initial steroid treatment. Low-dose maintenance treatment with systemic steroids should be considered to avoid recurrence in patients with elevated serum IgG4 levels.

IgG4-related lacrimal sac diverticulitis.

IgG4-related disease is characterized by elevated serum IgG4 and tissue infiltration by IgG4-positive plasma cells. We herein report a case of lacrimal sac diverticulitis with marked IgG4-positive plasma cell infiltration. An 89-year-old woman presenting with right lower eyelid mass. Imaging modalities demonstrated a cystic orbital mass located beneath the globe and adjacent to enlarged lacrimal sac. Serological tests showed high IgG4 and normal IgG levels, measuring 242 and 1603 mg/dl, respectively. The orbital mass was surgically excised. Histologically, the excised tissue demonstrated marked inflammation with fibrosis surrounded by mononuclear epithelial cells. A variety of IgG and IgG4-positive plasma cells infiltrated the stroma. This patient was diagnosed as an IgG4-related lacrimal sac diverticulitis, based on current diagnostic criteria of IgG4-related disease. It is likely that IgG4-related inflammation occurs in a lacrimal sac diverticulum, which should be considered a differential diagnosis in inferior orbital tumors.

Diagnóstico oftalmológico de una caso de telangiectasia hemorrágica hereditaria o enfermedad de Rendy-Osler-Weber / Ophthalmologic diagnosis of hereditary hemorrhagic telangiectasia or Rendu- Osler-Weber disease

Caso clínico: Mujer de 45 años con episodios recurrentes de epífora hemática espontánea. La paciente presentaba epistaxis de repetición no filiadas y, tenía antecedentes familiares de hemorragia digestiva, además una de sus hijas sufría de epistaxis. Discusión: El diagnóstico de telangiectasia hemorrágica hereditaria por oftalmólogos es un hecho infrecuente. La presencia de lágrimas con sangre o epífora hemática espontánea, en un paciente con historia de hemorragias de repetición en forma de epistaxis o hemorragia digestiva, nos tiene que hacer sospechar y buscar la presencia de esta enfermedad. La historia y exploración clínica son fundamentales en el diagnóstico de dicha enfermedad

Case report: Our patient was a 45-year-old woman who had recurrent episodes of hematic epiphora, repeated epistaxes for which no cause was found and a family history of gastric hemorrhage. One of her daughters also suffered from spontaneous hemorrhages. Discussion: Hereditary hemorrhagic telangiectasia is rarely diagnosed by an ophthalmologist; however the occurrence of bloody tears occurring spontaneously in a patient with epistaxis or gastric hemorrhage should lead to suspicion of hereditary hemorrhagic telangiectasia or Rendu-Osler-Weber disease. It should never be forgotten that clinical examination and appropriate investigations are basic components of disease diagnosis (Arch Soc Esp Oftalmol 2008; 83: 381-384)

Endonasal laser dacryocystorhinostomy: its role in anticoagulated patients.

OBJECTIVE: To report the results of endoscopic laser-assisted dacryocystorhinostomy in anticoagulated patients. STUDY DESIGN: A retrospective study of 16 consecutive anticoagulated patients with distal nasolacrimal duct obstruction treated by endoscopic laser-assisted dacryocystorhinostomy. METHODS: A case note review was made of all patients treated with endoscopic laser-assisted dacryocystorhinostomy who were taking coumadin in two centers between 1993 and 2000. The parameters of age, gender, indications for surgery, surgical findings, complications, and outcome were analyzed. The mean follow-up time was 14 months (range, 9-26 mo). RESULTS: Fifteen of the 16 patients who were treated had an eventual successful outcome, but 6 patients required revision surgery. The patient whose symptoms were not improved was shown to have functional epiphora. No patient had a problem with primary or secondary epistaxis, and no patient required admission. A major benefit was the lack of disruption of anticoagulant therapy. CONCLUSIONS: Endoscopic laser-assisted dacryocystorhinostomy is a safe, efficient technique for the relief of distal nasolacrimal duct obstruction in anticoagulated patients. Not only does it avoid any disruption to their anticoagulant therapy, but it also can be performed as an outpatient procedure.

The autoimmune nature of aqueous tear deficiency.

Twenty-two patients with aqueous tear deficiency (ATD) were examined for the presence of the following autoantibodies: immunofluorescent antinuclear antibody (ANA) and Sjögren's syndrome antibodies A and B (SS-A and SS-B). These autoantibodies were found in 17 (82%) patients but not in control subjects, and they correlated with the severity of symptoms and ocular surface changes. Bacterial keratitis, often recurrent and bilateral, and progressive sterile corneal stromal melting developed in six autoantibody-positive ATD patients. Eight antibody-positive patients had labial salivary or lacrimal gland biopsies, and all showed similar histologic features with marked destruction of the glandular architecture by lymphocytic infiltration. Immunoglobulin and complement were not detected in the glandular tissue. Circumstantial evidence suggests that an abnormal immunologic reaction, possibly related to Epstein-Barr viral (EBV) infection, is the cause of the glandular destruction and tear deficiency.